For example, a PET study focused on 5-HT1A receptor availability in schizophrenia patients treated with ziprasidone and found no significant difference in their distribution before or after receiving medication but found a significant association between 5-HT1A binding and improvement in negative symptoms51. Here, HTR1A is linked to schizophrenia.